Shalini Chilakala

Director, Bioanalysis for B Cell Therapy at Be Bio

Shalini Chilakala has held a variety of roles in the biopharmaceutical industry since 2005. Shalini began their career as a Research Assistant at Louisiana Tech University in 2005. In 2007, they joined Labcorp Drug Development as a Scientist, then moved up to Senior Research Scientist, Principal Scientist/ Manager, and Associate Research Scientist. In 2017, they joined Syneos Health as an Associate Director of Bioanalysis and Principal Research Scientist/ Group Leader. Most recently, they were appointed Director of Bioanalysis for B Cell Therapy at Be Biopharma in 2022.

Shalini Chilakala holds a Master of Science in Biomedical Engineering from Louisiana Tech University and a Bachelor of Engineering in Biomedical Engineering from Osmania University. Shalini has also obtained multiple certifications from LinkedIn, including "How to Effectively Deliver Criticism" (2022), "Leading and Motivating People with Different Personalities" (2022), "Bill George on Self-Awareness, Authenticity, and Leadership" (2020), "Creating Your Personal Brand" (2020), "Body Language for Leaders" (2018), "Developing Your Emotional Intelligence" (2018), "Learning to Be Assertive" (2018), and "Stepping Up to Leadership" (2017).

Links

Previous companies

Syneos Health logo

Timeline

  • Director, Bioanalysis for B Cell Therapy

    November, 2022 - present

View in org chart